569 results on '"Patterson, Adam"'
Search Results
52. Acknowledgments
53. Teaching Data Literacy and Sports Economic Fundamentals Using Fantasy Sports.
54. Synthesis and cytotoxicity of pyranonaphthoquinone natural product analogues under bioreductive conditions
55. Prevalence of serum immunoglobulin E against cross‐reactive carbohydrate determinants in allergic and nonallergic horses, and its impact on polysensitisation in serum allergen tests
56. Synthesis of substituted 5-bromomethyl-4-nitroimidazoles and use for the preparation of the hypoxia-selective multikinase inhibitor SN29966
57. Changes in blood pressure and heart rate during sedation with ketamine in the pediatric ED☆,☆☆
58. Characterization of the cutaneous mycobiota in healthy and allergic cats using next generation sequencing
59. Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4
60. Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based Modelling
61. Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications
62. Recognition of and Approach to Feline Cutaneous Reaction Patterns
63. Contributors
64. Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
65. Using a Fantasy Baseball Simulation to Teach Economic Concepts
66. Discovery of Cysteine-targeting Covalent Protein Kinase Inhibitors
67. Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3
68. Bioreductive prodrug PR-104 improves the tumour distribution and titre of the nitroreductase-armed oncolytic adenovirus ONYX-411NTR leading to therapeutic benefit
69. What is living on your dogʼs skin? Characterization of the canine cutaneous mycobiota and fungal dysbiosis in canine allergic dermatitis
70. Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
71. Fourth-Generation Analogues of the Anticancer Peptaibol Culicinin D: Probing the Effects of Hydrophobicity and Halogenation on Cytotoxicity
72. Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents
73. The determinants of complication trajectories in American Indians with type 2 diabetes
74. An industrial perspective on co-crystals: Screening, identification and development of the less utilised solid form in drug discovery and development
75. Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice
76. A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors
77. Synthesis and antiproliferative activity of C- and N-terminal analogues of culicinin D
78. Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5
79. Alanine scan-guided synthesis and biological evaluation of analogues of culicinin D, a potent anticancer peptaibol
80. PROGRAMMING A FANUC INDUSTRIAL ROBOT FOR INCREMENTAL SHEET FORMING.
81. A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells
82. Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
83. Selectively Targeting Tumor Hypoxia with the Hypoxia-Activated Prodrug CP-506
84. Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors
85. Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
86. Use of an optimised enzyme/prodrug combination for Clostridia directed enzyme prodrug therapy induces a significant growth delay in necrotic tumours
87. Leishmania mexicana in a central Texas cat: clinical presentation, molecular identification, sandfly vector collection and novel management
88. Unilateral abdominal clonic jerking as an epileptic phenomenon
89. Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A
90. Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4.
91. Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells
92. Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro
93. Molecular Chemotherapy for Breast Cancer
94. Prototyping kinase inhibitor-cytotoxin anticancer mutual prodrugs activated by tumour hypoxia: A chemical proof of concept study
95. Diabetes Educators in Safety-Net Practices: A Qualitative Study
96. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
97. Untargeted metabolomics yields insight into ALS disease mechanisms
98. Directed evolution of the B. subtilis nitroreductase YfkO improves activation of the PET-capable probe SN33623 and CB1954 prodrug
99. Epistemic Slurs: A Novel Explicandum and Adequacy Constraint for Slur Theories
100. 1992-P: Metabolic Factors Associated with Cognitive Function and Brain Morphology in Type 2 Diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.